{
    "Trade/Device Name(s)": [
        "Hp Detect Stool Antigen ELISA"
    ],
    "Submitter Information": "Biomerica, Inc.",
    "510(k) Number": "K232892",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182559"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LYR"
    ],
    "Summary Letter Date": "September 15, 2023",
    "Summary Letter Received Date": "September 18, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Helicobacter pylori antigen"
    ],
    "Specimen Type(s)": [
        "Stool",
        "Feces"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "96-well clear flat bottom polystyrene microplate"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Spectrophotometric detection"
    ],
    "Methodologies": [
        "Sandwich ELISA"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Control",
        "Microplate",
        "Buffer",
        "Wash solution",
        "Substrate",
        "Stop solution"
    ],
    "Document Summary": "FDA 510(k) summary for Hp Detect Stool Antigen ELISA, a qualitative sandwich enzyme immunoassay to detect Helicobacter pylori antigen in human stool specimens for diagnosis and post-treatment monitoring.",
    "Indications for Use Summary": "In vitro diagnostic qualitative enzyme immunoassay for detection of Helicobacter pylori antigens in human stool or feces to aid in initial and posttherapy diagnosis of H. pylori infection, including assessment of infection status after treatment (minimum 4 weeks post-therapy); for prescription use only.",
    "fda_folder": "Microbiology"
}